Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02083354
Brief Title: Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

First Submitted : February 13, 2014
First Submitted that Met QC Criteria : March 6, 2014
First Posted : March 11, 2014 (Estimate)

Results First Submitted : February 15, 2021
Results First Submitted that Met QC Criteria : March 16, 2021
Results First Posted : March 17, 2021

Certification/Extension First Submitted : October 10, 2018
Certification/Extension First Submitted that Met QC Criteria : February 11, 2019
Certification/Extension First Posted : February 15, 2019

Last Update Submitted that Met QC Criteria : April 22, 2021
Last Update Posted : May 13, 2021